TYMS and small cell lung carcinoma: Elevated expression of TYMS is believed to be one reason for the low efficacy of pemetrexed in SCLC [50]; similarly, squamous cell carcinomas of the lung express higher amounts of TYMS [51], which show poor response rates to pemetrexed-based therapies [49, 52].